IM Cannabis Corp. (NASDAQ: IMCC) Stock Competitors & Peer Comparison
See IMCC's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for IMCC and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| IMCC | $4.23 | +143.10% | 2.6M | -2.42 | -$1.75 | N/A |
| TAK | $18.91 | -0.73% | 60.2B | 13.60 | $1.39 | +3.32% |
| TEVA | $38.98 | -0.54% | 45.4B | 13.31 | $2.93 | N/A |
| HLN | $9.28 | -0.85% | 40.9B | 17.32 | $0.54 | +2.13% |
| ZTS | $71.40 | -2.22% | 30B | 10.86 | $6.58 | +2.89% |
| VTRS | $16.95 | -1.05% | 19.7B | 6.73 | $2.52 | +2.82% |
| ITCI | $131.87 | +0.00% | 14B | -180.64 | -$0.73 | N/A |
| CTLT | $63.48 | +0.00% | 11.5B | -27.84 | -$2.28 | N/A |
| ELAN | $22.42 | -1.41% | 11.2B | 21.15 | $1.06 | N/A |
| RDY | $12.19 | +0.00% | 10.2B | 19.99 | $0.61 | +0.68% |
Stock Comparison
Takeda Pharmaceutical Company Limited (NYSE: TAK)
IMCC vs TAK Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, TAK has a market cap of 60.2B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while TAK trades at $18.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas TAK's P/E ratio is 13.60. In terms of profitability, IMCC's ROE is +8.42%, compared to TAK's ROE of +0.02%. Regarding short-term risk, IMCC is more volatile compared to TAK. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check TAK's competition here
Teva Pharmaceutical Industries Limited (NYSE: TEVA)
IMCC vs TEVA Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, TEVA has a market cap of 45.4B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while TEVA trades at $38.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas TEVA's P/E ratio is 13.31. In terms of profitability, IMCC's ROE is +8.42%, compared to TEVA's ROE of +0.09%. Regarding short-term risk, IMCC is more volatile compared to TEVA. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check TEVA's competition here
Haleon plc (NYSE: HLN)
IMCC vs HLN Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, HLN has a market cap of 40.9B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while HLN trades at $9.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas HLN's P/E ratio is 17.32. In terms of profitability, IMCC's ROE is +8.42%, compared to HLN's ROE of +0.17%. Regarding short-term risk, IMCC is more volatile compared to HLN. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check HLN's competition here
Zoetis Inc. (NYSE: ZTS)
IMCC vs ZTS Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, ZTS has a market cap of 30B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while ZTS trades at $71.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas ZTS's P/E ratio is 10.86. In terms of profitability, IMCC's ROE is +8.42%, compared to ZTS's ROE of +0.69%. Regarding short-term risk, IMCC is more volatile compared to ZTS. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check ZTS's competition here
Viatris Inc. (NASDAQ: VTRS)
IMCC vs VTRS Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, VTRS has a market cap of 19.7B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while VTRS trades at $16.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas VTRS's P/E ratio is 6.73. In terms of profitability, IMCC's ROE is +8.42%, compared to VTRS's ROE of -0.03%. Regarding short-term risk, IMCC is more volatile compared to VTRS. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check VTRS's competition here
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI)
IMCC vs ITCI Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while ITCI trades at $131.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas ITCI's P/E ratio is -180.64. In terms of profitability, IMCC's ROE is +8.42%, compared to ITCI's ROE of -0.09%. Regarding short-term risk, IMCC is more volatile compared to ITCI. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check ITCI's competition here
Catalent, Inc. (NYSE: CTLT)
IMCC vs CTLT Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while CTLT trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas CTLT's P/E ratio is -27.84. In terms of profitability, IMCC's ROE is +8.42%, compared to CTLT's ROE of -0.25%. Regarding short-term risk, IMCC is more volatile compared to CTLT. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check CTLT's competition here
Elanco Animal Health Incorporated (NYSE: ELAN)
IMCC vs ELAN Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, ELAN has a market cap of 11.2B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while ELAN trades at $22.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas ELAN's P/E ratio is 21.15. In terms of profitability, IMCC's ROE is +8.42%, compared to ELAN's ROE of -0.03%. Regarding short-term risk, IMCC is more volatile compared to ELAN. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check ELAN's competition here
Dr. Reddy's Laboratories Limited (NYSE: RDY)
IMCC vs RDY Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, RDY has a market cap of 10.2B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while RDY trades at $12.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas RDY's P/E ratio is 19.99. In terms of profitability, IMCC's ROE is +8.42%, compared to RDY's ROE of +0.09%. Regarding short-term risk, IMCC is more volatile compared to RDY. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check RDY's competition here
Alkermes plc (NASDAQ: ALKS)
IMCC vs ALKS Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, ALKS has a market cap of 7.8B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while ALKS trades at $43.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas ALKS's P/E ratio is 49.17. In terms of profitability, IMCC's ROE is +8.42%, compared to ALKS's ROE of +0.04%. Regarding short-term risk, IMCC is more volatile compared to ALKS. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check ALKS's competition here
Lantheus Holdings, Inc. (NASDAQ: LNTH)
IMCC vs LNTH Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, LNTH has a market cap of 6.5B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while LNTH trades at $100.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas LNTH's P/E ratio is 16.90. In terms of profitability, IMCC's ROE is +8.42%, compared to LNTH's ROE of +0.23%. Regarding short-term risk, IMCC is more volatile compared to LNTH. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check LNTH's competition here
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX)
IMCC vs AMRX Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, AMRX has a market cap of 5.8B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while AMRX trades at $18.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas AMRX's P/E ratio is 20.31. In terms of profitability, IMCC's ROE is +8.42%, compared to AMRX's ROE of -3.27%. Regarding short-term risk, IMCC is more volatile compared to AMRX. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check AMRX's competition here
Indivior Pharmaceuticals Inc (NASDAQ: INDV)
IMCC vs INDV Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, INDV has a market cap of 4.4B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while INDV trades at $34.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas INDV's P/E ratio is 9.56. In terms of profitability, IMCC's ROE is +8.42%, compared to INDV's ROE of -2.16%. Regarding short-term risk, IMCC is more volatile compared to INDV. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check INDV's competition here
Alvotech (NASDAQ: ALVOW)
IMCC vs ALVOW Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, ALVOW has a market cap of 3B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while ALVOW trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas ALVOW's P/E ratio is 46.65. In terms of profitability, IMCC's ROE is +8.42%, compared to ALVOW's ROE of +0.77%. Regarding short-term risk, IMCC is more volatile compared to ALVOW. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check ALVOW's competition here
Regencell Bioscience Holdings Limited (NASDAQ: RGC)
IMCC vs RGC Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, RGC has a market cap of 2.9B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while RGC trades at $5.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas RGC's P/E ratio is -407.75. In terms of profitability, IMCC's ROE is +8.42%, compared to RGC's ROE of -2.32%. Regarding short-term risk, IMCC is more volatile compared to RGC. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check RGC's competition here
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)
IMCC vs SUPN Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, SUPN has a market cap of 2.4B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while SUPN trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas SUPN's P/E ratio is 13.73. In terms of profitability, IMCC's ROE is +8.42%, compared to SUPN's ROE of -0.10%. Regarding short-term risk, IMCC is more volatile compared to SUPN. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check SUPN's competition here
HUTCHMED (China) Limited (NASDAQ: HCM)
IMCC vs HCM Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, HCM has a market cap of 2.4B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while HCM trades at $13.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas HCM's P/E ratio is 5.12. In terms of profitability, IMCC's ROE is +8.42%, compared to HCM's ROE of +0.01%. Regarding short-term risk, IMCC is more volatile compared to HCM. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check HCM's competition here
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH)
IMCC vs DCPH Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while DCPH trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas DCPH's P/E ratio is -11.58. In terms of profitability, IMCC's ROE is +8.42%, compared to DCPH's ROE of -0.56%. Regarding short-term risk, IMCC is more volatile compared to DCPH. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check DCPH's competition here
Avadel Pharmaceuticals plc (NASDAQ: AVDL)
IMCC vs AVDL Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, AVDL has a market cap of 2.1B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while AVDL trades at $21.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas AVDL's P/E ratio is -1082.00. In terms of profitability, IMCC's ROE is +8.42%, compared to AVDL's ROE of +0.05%. Regarding short-term risk, IMCC is more volatile compared to AVDL. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check AVDL's competition here
Bausch Health Companies Inc. (NYSE: BHC)
IMCC vs BHC Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, BHC has a market cap of 2.1B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while BHC trades at $5.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas BHC's P/E ratio is 1.45. In terms of profitability, IMCC's ROE is +8.42%, compared to BHC's ROE of +0.89%. Regarding short-term risk, IMCC is more volatile compared to BHC. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check BHC's competition here
Embecta Corp. (NASDAQ: EMBCV)
IMCC vs EMBCV Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while EMBCV trades at $33.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas EMBCV's P/E ratio is N/A. In terms of profitability, IMCC's ROE is +8.42%, compared to EMBCV's ROE of -0.19%. Regarding short-term risk, IMCC is more volatile compared to EMBCV. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check EMBCV's competition here
Trulieve Cannabis Corp. (NYSE: TRLV)
IMCC vs TRLV Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, TRLV has a market cap of 1.9B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while TRLV trades at $11.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas TRLV's P/E ratio is -4.50. In terms of profitability, IMCC's ROE is +8.42%, compared to TRLV's ROE of -0.44%. Regarding short-term risk, IMCC is more volatile compared to TRLV. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check TRLV's competition here
Perrigo Company plc (NYSE: PRGO)
IMCC vs PRGO Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, PRGO has a market cap of 1.9B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while PRGO trades at $13.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas PRGO's P/E ratio is 5.44. In terms of profitability, IMCC's ROE is +8.42%, compared to PRGO's ROE of -0.56%. Regarding short-term risk, IMCC is more volatile compared to PRGO. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check PRGO's competition here
Dynavax Technologies Corporation (NASDAQ: DVAX)
IMCC vs DVAX Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, DVAX has a market cap of 1.8B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while DVAX trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas DVAX's P/E ratio is -41.89. In terms of profitability, IMCC's ROE is +8.42%, compared to DVAX's ROE of -0.10%. Regarding short-term risk, IMCC is more volatile compared to DVAX. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check DVAX's competition here
Alvotech (NASDAQ: ALVO)
IMCC vs ALVO Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, ALVO has a market cap of 1.8B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while ALVO trades at $5.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas ALVO's P/E ratio is -15.71. In terms of profitability, IMCC's ROE is +8.42%, compared to ALVO's ROE of +0.77%. Regarding short-term risk, IMCC is more volatile compared to ALVO. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check ALVO's competition here
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP)
IMCC vs ANIP Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, ANIP has a market cap of 1.7B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while ANIP trades at $76.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas ANIP's P/E ratio is 9.26. In terms of profitability, IMCC's ROE is +8.42%, compared to ANIP's ROE of +0.19%. Regarding short-term risk, IMCC is more volatile compared to ANIP. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check ANIP's competition here
Taro Pharmaceutical Industries Ltd. (NYSE: TARO)
IMCC vs TARO Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while TARO trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas TARO's P/E ratio is 30.05. In terms of profitability, IMCC's ROE is +8.42%, compared to TARO's ROE of +0.03%. Regarding short-term risk, IMCC is more volatile compared to TARO. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check TARO's competition here
Eton Pharmaceuticals, Inc. (NASDAQ: ETON)
IMCC vs ETON Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, ETON has a market cap of 1.5B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while ETON trades at $55.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas ETON's P/E ratio is 120.65. In terms of profitability, IMCC's ROE is +8.42%, compared to ETON's ROE of +0.40%. Regarding short-term risk, IMCC is more volatile compared to ETON. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check ETON's competition here
Phibro Animal Health Corporation (NASDAQ: PAHC)
IMCC vs PAHC Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, PAHC has a market cap of 1.4B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while PAHC trades at $34.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas PAHC's P/E ratio is 11.80. In terms of profitability, IMCC's ROE is +8.42%, compared to PAHC's ROE of +0.29%. Regarding short-term risk, IMCC is more volatile compared to PAHC. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check PAHC's competition here
Cronos Group Inc. (NASDAQ: CRON)
IMCC vs CRON Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, CRON has a market cap of 1.3B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while CRON trades at $3.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas CRON's P/E ratio is 31.81. In terms of profitability, IMCC's ROE is +8.42%, compared to CRON's ROE of +0.06%. Regarding short-term risk, IMCC is more volatile compared to CRON. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check CRON's competition here
Harrow Health, Inc. (NASDAQ: HROW)
IMCC vs HROW Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, HROW has a market cap of 1.2B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while HROW trades at $33.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas HROW's P/E ratio is -33.41. In terms of profitability, IMCC's ROE is +8.42%, compared to HROW's ROE of -1.04%. Regarding short-term risk, IMCC is more volatile compared to HROW. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check HROW's competition here
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH)
IMCC vs AMPH Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, AMPH has a market cap of 1.1B. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while AMPH trades at $23.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas AMPH's P/E ratio is 8.13. In terms of profitability, IMCC's ROE is +8.42%, compared to AMPH's ROE of +0.10%. Regarding short-term risk, IMCC is more volatile compared to AMPH. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check AMPH's competition here
Pacira BioSciences, Inc. (NASDAQ: PCRX)
IMCC vs PCRX Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, PCRX has a market cap of 971.2M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while PCRX trades at $24.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas PCRX's P/E ratio is 9.50. In terms of profitability, IMCC's ROE is +8.42%, compared to PCRX's ROE of +0.02%. Regarding short-term risk, IMCC is more volatile compared to PCRX. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check PCRX's competition here
PetIQ, Inc. (NASDAQ: PETQ)
IMCC vs PETQ Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, PETQ has a market cap of 919.2M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while PETQ trades at $30.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas PETQ's P/E ratio is 83.73. In terms of profitability, IMCC's ROE is +8.42%, compared to PETQ's ROE of +0.01%. Regarding short-term risk, IMCC is more volatile compared to PETQ. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check PETQ's competition here
Collegium Pharmaceutical, Inc. (NASDAQ: COLL)
IMCC vs COLL Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, COLL has a market cap of 738.5M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while COLL trades at $22.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas COLL's P/E ratio is 2.86. In terms of profitability, IMCC's ROE is +8.42%, compared to COLL's ROE of +0.16%. Regarding short-term risk, IMCC is more volatile compared to COLL. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check COLL's competition here
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD)
IMCC vs IRWD Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, IRWD has a market cap of 717.7M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while IRWD trades at $4.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas IRWD's P/E ratio is 5.59. In terms of profitability, IMCC's ROE is +8.42%, compared to IRWD's ROE of -0.57%. Regarding short-term risk, IMCC is more volatile compared to IRWD. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check IRWD's competition here
Glass House Brands Inc (NYSE: GLAS)
IMCC vs GLAS Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, GLAS has a market cap of 614M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while GLAS trades at $7.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas GLAS's P/E ratio is -14.17. In terms of profitability, IMCC's ROE is +8.42%, compared to GLAS's ROE of -0.51%. Regarding short-term risk, IMCC is more volatile compared to GLAS. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check GLAS's competition here
Aquestive Therapeutics, Inc. (NASDAQ: AQST)
IMCC vs AQST Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, AQST has a market cap of 578.4M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while AQST trades at $4.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas AQST's P/E ratio is -7.09. In terms of profitability, IMCC's ROE is +8.42%, compared to AQST's ROE of +2.44%. Regarding short-term risk, IMCC is more volatile compared to AQST. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check AQST's competition here
BioDelivery Sciences International, Inc. (NASDAQ: BDSI)
IMCC vs BDSI Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while BDSI trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas BDSI's P/E ratio is 6.82. In terms of profitability, IMCC's ROE is +8.42%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, IMCC is more volatile compared to BDSI. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check BDSI's competition here
Evotec SE (NASDAQ: EVO)
IMCC vs EVO Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, EVO has a market cap of 568.4M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while EVO trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas EVO's P/E ratio is -2.26. In terms of profitability, IMCC's ROE is +8.42%, compared to EVO's ROE of -0.27%. Regarding short-term risk, IMCC is more volatile compared to EVO. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check EVO's competition here
Evolus, Inc. (NASDAQ: EOLS)
IMCC vs EOLS Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, EOLS has a market cap of 517.6M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while EOLS trades at $7.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas EOLS's P/E ratio is -24.89. In terms of profitability, IMCC's ROE is +8.42%, compared to EOLS's ROE of +1.23%. Regarding short-term risk, IMCC is more volatile compared to EOLS. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check EOLS's competition here
Kamada Ltd. (NASDAQ: KMDA)
IMCC vs KMDA Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, KMDA has a market cap of 510.6M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while KMDA trades at $8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas KMDA's P/E ratio is 23.29. In terms of profitability, IMCC's ROE is +8.42%, compared to KMDA's ROE of +0.08%. Regarding short-term risk, IMCC is more volatile compared to KMDA. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check KMDA's competition here
Tilray Brands, Inc. (NASDAQ: TLRY)
IMCC vs TLRY Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, TLRY has a market cap of 446.2M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while TLRY trades at $3.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas TLRY's P/E ratio is -3.68. In terms of profitability, IMCC's ROE is +8.42%, compared to TLRY's ROE of -0.08%. Regarding short-term risk, IMCC is more volatile compared to TLRY. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check TLRY's competition here
Alpha Teknova, Inc. (NASDAQ: TKNO)
IMCC vs TKNO Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, TKNO has a market cap of 417.7M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while TKNO trades at $7.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas TKNO's P/E ratio is -25.13. In terms of profitability, IMCC's ROE is +8.42%, compared to TKNO's ROE of -0.25%. Regarding short-term risk, IMCC is more volatile compared to TKNO. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check TKNO's competition here
Canopy Growth Corporation (NASDAQ: CGC)
IMCC vs CGC Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, CGC has a market cap of 394.5M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while CGC trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas CGC's P/E ratio is -2.09. In terms of profitability, IMCC's ROE is +8.42%, compared to CGC's ROE of -0.33%. Regarding short-term risk, IMCC is more volatile compared to CGC. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check CGC's competition here
Emergent BioSolutions Inc. (NYSE: EBS)
IMCC vs EBS Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, EBS has a market cap of 349.8M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while EBS trades at $6.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas EBS's P/E ratio is 4.71. In terms of profitability, IMCC's ROE is +8.42%, compared to EBS's ROE of -0.36%. Regarding short-term risk, IMCC is more volatile compared to EBS. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check EBS's competition here
Alimera Sciences, Inc. (NASDAQ: ALIM)
IMCC vs ALIM Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while ALIM trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas ALIM's P/E ratio is 5.28. In terms of profitability, IMCC's ROE is +8.42%, compared to ALIM's ROE of -1.59%. Regarding short-term risk, IMCC is more volatile compared to ALIM. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check ALIM's competition here
Landec Corporation (NASDAQ: LNDC)
IMCC vs LNDC Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while LNDC trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas LNDC's P/E ratio is -4.04. In terms of profitability, IMCC's ROE is +8.42%, compared to LNDC's ROE of +6.44%. Regarding short-term risk, IMCC is more volatile compared to LNDC. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check LNDC's competition here
Aurora Cannabis Inc. (NASDAQ: ACB)
IMCC vs ACB Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, ACB has a market cap of 239.7M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while ACB trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas ACB's P/E ratio is -2.79. In terms of profitability, IMCC's ROE is +8.42%, compared to ACB's ROE of -0.21%. Regarding short-term risk, IMCC is more volatile compared to ACB. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check ACB's competition here
Shineco, Inc. (NASDAQ: TYHT)
IMCC vs TYHT Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while TYHT trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas TYHT's P/E ratio is -1.61. In terms of profitability, IMCC's ROE is +8.42%, compared to TYHT's ROE of -0.57%. Regarding short-term risk, IMCC is more volatile compared to TYHT. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check TYHT's competition here
SIGA Technologies, Inc. (NASDAQ: SIGA)
IMCC vs SIGA Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, SIGA has a market cap of 225.2M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while SIGA trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas SIGA's P/E ratio is 11.63. In terms of profitability, IMCC's ROE is +8.42%, compared to SIGA's ROE of -0.02%. Regarding short-term risk, IMCC is more volatile compared to SIGA. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check SIGA's competition here
Cardiol Therapeutics Inc. (NASDAQ: CRDL)
IMCC vs CRDL Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, CRDL has a market cap of 216.1M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while CRDL trades at $1.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas CRDL's P/E ratio is -7.47. In terms of profitability, IMCC's ROE is +8.42%, compared to CRDL's ROE of -1.94%. Regarding short-term risk, IMCC is more volatile compared to CRDL. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check CRDL's competition here
Journey Medical Corporation (NASDAQ: DERM)
IMCC vs DERM Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, DERM has a market cap of 201.2M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while DERM trades at $7.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas DERM's P/E ratio is -19.76. In terms of profitability, IMCC's ROE is +8.42%, compared to DERM's ROE of -0.20%. Regarding short-term risk, IMCC is more volatile compared to DERM. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check DERM's competition here
Organogenesis Holdings Inc. (NASDAQ: ORGO)
IMCC vs ORGO Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, ORGO has a market cap of 182.7M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while ORGO trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas ORGO's P/E ratio is 47.33. In terms of profitability, IMCC's ROE is +8.42%, compared to ORGO's ROE of -0.24%. Regarding short-term risk, IMCC is more volatile compared to ORGO. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check ORGO's competition here
Recro Pharma, Inc. (NASDAQ: REPH)
IMCC vs REPH Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while REPH trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas REPH's P/E ratio is -8.04. In terms of profitability, IMCC's ROE is +8.42%, compared to REPH's ROE of -0.22%. Regarding short-term risk, IMCC is more volatile compared to REPH. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check REPH's competition here
Lifecore Biomedical, Inc. (NASDAQ: LFCR)
IMCC vs LFCR Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, LFCR has a market cap of 167.3M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while LFCR trades at $4.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas LFCR's P/E ratio is -4.17. In terms of profitability, IMCC's ROE is +8.42%, compared to LFCR's ROE of -3.77%. Regarding short-term risk, IMCC is more volatile compared to LFCR. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check LFCR's competition here
Theratechnologies Inc. (NASDAQ: THTX)
IMCC vs THTX Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, THTX has a market cap of 155.9M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while THTX trades at $3.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas THTX's P/E ratio is -28.83. In terms of profitability, IMCC's ROE is +8.42%, compared to THTX's ROE of +0.36%. Regarding short-term risk, IMCC is more volatile compared to THTX. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check THTX's competition here
Assertio Holdings, Inc. (NASDAQ: ASRT)
IMCC vs ASRT Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, ASRT has a market cap of 151.9M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while ASRT trades at $23.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas ASRT's P/E ratio is -7.10. In terms of profitability, IMCC's ROE is +8.42%, compared to ASRT's ROE of -0.39%. Regarding short-term risk, IMCC is more volatile compared to ASRT. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check ASRT's competition here
Organigram Global Inc. (NASDAQ: OGI)
IMCC vs OGI Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, OGI has a market cap of 147.8M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while OGI trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas OGI's P/E ratio is 2.36. In terms of profitability, IMCC's ROE is +8.42%, compared to OGI's ROE of +0.21%. Regarding short-term risk, IMCC is more volatile compared to OGI. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check OGI's competition here
Societal CDMO, Inc. (NASDAQ: SCTL)
IMCC vs SCTL Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while SCTL trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas SCTL's P/E ratio is -7.86. In terms of profitability, IMCC's ROE is +8.42%, compared to SCTL's ROE of -0.22%. Regarding short-term risk, IMCC is more volatile compared to SCTL. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check SCTL's competition here
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX)
IMCC vs CPIX Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, CPIX has a market cap of 109.7M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while CPIX trades at $7.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas CPIX's P/E ratio is -18.30. In terms of profitability, IMCC's ROE is +8.42%, compared to CPIX's ROE of -0.47%. Regarding short-term risk, IMCC is more volatile compared to CPIX. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check CPIX's competition here
Procaps Group S.A. (NASDAQ: PROC)
IMCC vs PROC Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, PROC has a market cap of 102.1M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while PROC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas PROC's P/E ratio is 1.53. In terms of profitability, IMCC's ROE is +8.42%, compared to PROC's ROE of -2.22%. Regarding short-term risk, IMCC is more volatile compared to PROC. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check PROC's competition here
BGM Group Ltd. (NASDAQ: BGM)
IMCC vs BGM Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, BGM has a market cap of 98.5M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while BGM trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas BGM's P/E ratio is -0.89. In terms of profitability, IMCC's ROE is +8.42%, compared to BGM's ROE of -0.05%. Regarding short-term risk, IMCC is more volatile compared to BGM. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check BGM's competition here
OptiNose, Inc. (NASDAQ: OPTN)
IMCC vs OPTN Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while OPTN trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas OPTN's P/E ratio is -4.42. In terms of profitability, IMCC's ROE is +8.42%, compared to OPTN's ROE of +0.34%. Regarding short-term risk, IMCC is more volatile compared to OPTN. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check OPTN's competition here
Zomedica Corp. (AMEX: ZOM)
IMCC vs ZOM Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while ZOM trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas ZOM's P/E ratio is -1.62. In terms of profitability, IMCC's ROE is +8.42%, compared to ZOM's ROE of -0.17%. Regarding short-term risk, IMCC is more volatile compared to ZOM. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check ZOM's competition here
Upexi, Inc. (NASDAQ: GRVI)
IMCC vs GRVI Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while GRVI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas GRVI's P/E ratio is 26.05. In terms of profitability, IMCC's ROE is +8.42%, compared to GRVI's ROE of -4.51%. Regarding short-term risk, IMCC is more volatile compared to GRVI. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check GRVI's competition here
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE)
IMCC vs ZYNE Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while ZYNE trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, IMCC's ROE is +8.42%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, IMCC is more volatile compared to ZYNE. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check ZYNE's competition here
Silver Spike Investment Corp. (NASDAQ: SSIC)
IMCC vs SSIC Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while SSIC trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas SSIC's P/E ratio is 11.93. In terms of profitability, IMCC's ROE is +8.42%, compared to SSIC's ROE of +0.00%. Regarding short-term risk, IMCC is more volatile compared to SSIC. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check SSIC's competition here
Zhengye Biotechnology Holding Limited (NASDAQ: ZYBT)
IMCC vs ZYBT Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, ZYBT has a market cap of 64.9M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while ZYBT trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas ZYBT's P/E ratio is -6.23. In terms of profitability, IMCC's ROE is +8.42%, compared to ZYBT's ROE of -0.27%. Regarding short-term risk, IMCC is more volatile compared to ZYBT. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check ZYBT's competition here
InterCure Ltd. (NASDAQ: INCR)
IMCC vs INCR Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, INCR has a market cap of 62.8M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while INCR trades at $5.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas INCR's P/E ratio is -12.23. In terms of profitability, IMCC's ROE is +8.42%, compared to INCR's ROE of -0.09%. Regarding short-term risk, IMCC is more volatile compared to INCR. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check INCR's competition here
The Valens Company Inc. (NASDAQ: VLNS)
IMCC vs VLNS Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while VLNS trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas VLNS's P/E ratio is -1.03. In terms of profitability, IMCC's ROE is +8.42%, compared to VLNS's ROE of N/A. Regarding short-term risk, IMCC is more volatile compared to VLNS. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check VLNS's competition here
Talphera, Inc. (NASDAQ: TLPH)
IMCC vs TLPH Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, TLPH has a market cap of 60.2M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while TLPH trades at $1.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas TLPH's P/E ratio is -3.74. In terms of profitability, IMCC's ROE is +8.42%, compared to TLPH's ROE of -0.87%. Regarding short-term risk, IMCC is more volatile compared to TLPH. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check TLPH's competition here
DURECT Corporation (NASDAQ: DRRX)
IMCC vs DRRX Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, DRRX has a market cap of 59.3M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while DRRX trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas DRRX's P/E ratio is -4.44. In terms of profitability, IMCC's ROE is +8.42%, compared to DRRX's ROE of -1.40%. Regarding short-term risk, IMCC is more volatile compared to DRRX. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check DRRX's competition here
Jupiter Wellness, Inc. (NASDAQ: JUPW)
IMCC vs JUPW Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while JUPW trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas JUPW's P/E ratio is -2.41. In terms of profitability, IMCC's ROE is +8.42%, compared to JUPW's ROE of -3.04%. Regarding short-term risk, IMCC is more volatile compared to JUPW. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check JUPW's competition here
Qilian International Holding Group Limited (NASDAQ: QLI)
IMCC vs QLI Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while QLI trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas QLI's P/E ratio is -4.92. In terms of profitability, IMCC's ROE is +8.42%, compared to QLI's ROE of -0.16%. Regarding short-term risk, IMCC is more volatile compared to QLI. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check QLI's competition here
Rockwell Medical, Inc. (NASDAQ: RMTI)
IMCC vs RMTI Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, RMTI has a market cap of 31.8M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while RMTI trades at $8.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas RMTI's P/E ratio is -6.02. In terms of profitability, IMCC's ROE is +8.42%, compared to RMTI's ROE of -0.14%. Regarding short-term risk, IMCC is more volatile compared to RMTI. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check RMTI's competition here
HEXO Corp. (NASDAQ: HEXO)
IMCC vs HEXO Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while HEXO trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas HEXO's P/E ratio is -0.26. In terms of profitability, IMCC's ROE is +8.42%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, IMCC is more volatile compared to HEXO. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check HEXO's competition here
China Pharma Holdings, Inc. (AMEX: CPHI)
IMCC vs CPHI Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, CPHI has a market cap of 28.8M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while CPHI trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas CPHI's P/E ratio is -1.65. In terms of profitability, IMCC's ROE is +8.42%, compared to CPHI's ROE of -0.17%. Regarding short-term risk, IMCC is more volatile compared to CPHI. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check CPHI's competition here
TherapeuticsMD, Inc. (NASDAQ: TXMD)
IMCC vs TXMD Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, TXMD has a market cap of 25.3M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while TXMD trades at $2.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas TXMD's P/E ratio is 111.56. In terms of profitability, IMCC's ROE is +8.42%, compared to TXMD's ROE of -0.01%. Regarding short-term risk, IMCC is more volatile compared to TXMD. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check TXMD's competition here
Cyclo Therapeutics, Inc. (NASDAQ: CYTH)
IMCC vs CYTH Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while CYTH trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas CYTH's P/E ratio is -0.80. In terms of profitability, IMCC's ROE is +8.42%, compared to CYTH's ROE of -7.30%. Regarding short-term risk, IMCC is more volatile compared to CYTH. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check CYTH's competition here
Aytu BioPharma, Inc. (NASDAQ: AYTU)
IMCC vs AYTU Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, AYTU has a market cap of 22.8M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while AYTU trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas AYTU's P/E ratio is -1.10. In terms of profitability, IMCC's ROE is +8.42%, compared to AYTU's ROE of -1.49%. Regarding short-term risk, IMCC is more volatile compared to AYTU. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check AYTU's competition here
Evoke Pharma, Inc. (NASDAQ: EVOK)
IMCC vs EVOK Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, EVOK has a market cap of 18.9M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while EVOK trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas EVOK's P/E ratio is -7.97. In terms of profitability, IMCC's ROE is +8.42%, compared to EVOK's ROE of -0.89%. Regarding short-term risk, IMCC is more volatile compared to EVOK. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check EVOK's competition here
Optimi Health Corp. (NASDAQ: OPTH)
IMCC vs OPTH Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, OPTH has a market cap of 16.1M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while OPTH trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas OPTH's P/E ratio is -18.26. In terms of profitability, IMCC's ROE is +8.42%, compared to OPTH's ROE of -0.90%. Regarding short-term risk, IMCC is more volatile compared to OPTH. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check OPTH's competition here
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX)
IMCC vs ACRX Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while ACRX trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas ACRX's P/E ratio is -0.31. In terms of profitability, IMCC's ROE is +8.42%, compared to ACRX's ROE of -0.87%. Regarding short-term risk, IMCC is more volatile compared to ACRX. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check ACRX's competition here
Caring Brands, Inc. (NASDAQ: CABR)
IMCC vs CABR Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, CABR has a market cap of 12.7M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while CABR trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas CABR's P/E ratio is -2.50. In terms of profitability, IMCC's ROE is +8.42%, compared to CABR's ROE of -3.86%. Regarding short-term risk, IMCC is more volatile compared to CABR. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check CABR's competition here
Agile Therapeutics, Inc. (NASDAQ: AGRX)
IMCC vs AGRX Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while AGRX trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas AGRX's P/E ratio is -0.89. In terms of profitability, IMCC's ROE is +8.42%, compared to AGRX's ROE of +1.32%. Regarding short-term risk, IMCC is more volatile compared to AGRX. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check AGRX's competition here
Neoleukin Therapeutics, Inc. (NASDAQ: NLTX)
IMCC vs NLTX Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while NLTX trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas NLTX's P/E ratio is -0.28. In terms of profitability, IMCC's ROE is +8.42%, compared to NLTX's ROE of -0.45%. Regarding short-term risk, IMCC is more volatile compared to NLTX. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check NLTX's competition here
Lannett Company, Inc. (NYSE: LCI)
IMCC vs LCI Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, LCI has a market cap of 7.4M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while LCI trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas LCI's P/E ratio is -0.04. In terms of profitability, IMCC's ROE is +8.42%, compared to LCI's ROE of +1.66%. Regarding short-term risk, IMCC is more volatile compared to LCI. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check LCI's competition here
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP)
IMCC vs ADMP Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, ADMP has a market cap of 7.3M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while ADMP trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas ADMP's P/E ratio is -0.08. In terms of profitability, IMCC's ROE is +8.42%, compared to ADMP's ROE of -2.09%. Regarding short-term risk, IMCC is more volatile compared to ADMP. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check ADMP's competition here
Gelteq Limited Ordinary Shares (NASDAQ: GELS)
IMCC vs GELS Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, GELS has a market cap of 5.2M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while GELS trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas GELS's P/E ratio is -1.12. In terms of profitability, IMCC's ROE is +8.42%, compared to GELS's ROE of -0.25%. Regarding short-term risk, IMCC is more volatile compared to GELS. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check GELS's competition here
cbdMD, Inc. (AMEX: YCBD)
IMCC vs YCBD Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, YCBD has a market cap of 4.7M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while YCBD trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas YCBD's P/E ratio is -1.11. In terms of profitability, IMCC's ROE is +8.42%, compared to YCBD's ROE of -0.34%. Regarding short-term risk, IMCC is more volatile compared to YCBD. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check YCBD's competition here
Mallinckrodt plc (AMEX: MNK)
IMCC vs MNK Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, MNK has a market cap of 4.5M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while MNK trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas MNK's P/E ratio is -0.44. In terms of profitability, IMCC's ROE is +8.42%, compared to MNK's ROE of -0.36%. Regarding short-term risk, IMCC is more volatile compared to MNK. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check MNK's competition here
Flora Growth Corp. (NASDAQ: FLGC)
IMCC vs FLGC Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, FLGC has a market cap of 4.2M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while FLGC trades at $7.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas FLGC's P/E ratio is -0.19. In terms of profitability, IMCC's ROE is +8.42%, compared to FLGC's ROE of -3.03%. Regarding short-term risk, IMCC is more volatile compared to FLGC. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check FLGC's competition here
Universe Pharmaceuticals Inc. (NASDAQ: UPC)
IMCC vs UPC Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, UPC has a market cap of 3M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while UPC trades at $4.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas UPC's P/E ratio is -0.60. In terms of profitability, IMCC's ROE is +8.42%, compared to UPC's ROE of -0.03%. Regarding short-term risk, IMCC is more volatile compared to UPC. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check UPC's competition here
PLx Pharma Inc. (NASDAQ: PLXP)
IMCC vs PLXP Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, PLXP has a market cap of 2.5M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while PLXP trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas PLXP's P/E ratio is -0.22. In terms of profitability, IMCC's ROE is +8.42%, compared to PLXP's ROE of -1.66%. Regarding short-term risk, IMCC is more volatile compared to PLXP. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check PLXP's competition here
InMed Pharmaceuticals Inc. (NASDAQ: INM)
IMCC vs INM Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, INM has a market cap of 2.5M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while INM trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas INM's P/E ratio is -0.25. In terms of profitability, IMCC's ROE is +8.42%, compared to INM's ROE of -1.35%. Regarding short-term risk, IMCC is more volatile compared to INM. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check INM's competition here
Athenex, Inc. (NASDAQ: ATNX)
IMCC vs ATNX Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, ATNX has a market cap of 2.3M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while ATNX trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas ATNX's P/E ratio is -0.02. In terms of profitability, IMCC's ROE is +8.42%, compared to ATNX's ROE of +0.22%. Regarding short-term risk, IMCC is more volatile compared to ATNX. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check ATNX's competition here
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA)
IMCC vs SNOA Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, SNOA has a market cap of 2.2M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while SNOA trades at $1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas SNOA's P/E ratio is -1.08. In terms of profitability, IMCC's ROE is +8.42%, compared to SNOA's ROE of -0.54%. Regarding short-term risk, IMCC is more volatile compared to SNOA. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check SNOA's competition here
Sunshine Biopharma, Inc. (NASDAQ: SBFM)
IMCC vs SBFM Comparison September 2026
IM Cannabis Corp. (NASDAQ: IMCC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMCC stands at 2.6M. In comparison, SBFM has a market cap of 2.1M. Regarding current trading prices, IMCC is priced at $4.23 on the NASDAQ, while SBFM trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMCC currently has a P/E ratio of -2.42, whereas SBFM's P/E ratio is -0.15. In terms of profitability, IMCC's ROE is +8.42%, compared to SBFM's ROE of -0.24%. Regarding short-term risk, IMCC is more volatile compared to SBFM. This indicates higher risk in terms of short-term price fluctuations for IMCC.Check SBFM's competition here